Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of intravesical
instillation of EO9 in patients with non-muscle invasive bladder cancer (NMIBC).